Acasă › Leucemie limfatică cronică › Minnesota › Rochester
Studii clinice pentru Leucemie limfatică cronică în Rochester, MN
19 studii pentru Leucemie limfatică cronică caută participanți în și în jurul orașului Rochester (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
În curs de recrutareFaza 2
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
În curs de recrutareFaza 1/2
- Research Site, Rochester
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
În curs de recrutareFaza 3
- Mayo Clinic Rochester, Rochester
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
În curs de recrutareFaza 1/2
- Mayo Clinic Rochester, Rochester
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
În curs de recrutareFaza 3
- Mayo Clinic Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
În curs de recrutareFaza 3
- Mayo Clinic Rochester, Rochester
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
În curs de recrutareFaza 1
- Mayo Clinic Rochester, Rochester
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
În curs de recrutareFaza 1/2
- Mayo Clinic, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
În curs de recrutareFaza 1/2
- Mayo Clinic, Clinical Trials Referral Office, Rochester
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
În curs de recrutareFaza 2
- Mayo Clinic, Rochester
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
În curs de recrutareFaza 1
- Mayo Clinic in Rochester, Rochester
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
În curs de recrutareVoluntari sănătoși bineveniți
- Mayo Clinic in Rochester, Rochester
Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Mayo Clinic in Rochester, Rochester
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
În curs de recrutareFaza 2
- Mayo Clinic in Rochester, Rochester
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
În curs de recrutareFaza 4
- Mayo Clinic- Minnesota, Rochester
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
În curs de recrutareFaza 4
- Mayo Clinic- Minnesota, Rochester
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
În curs de recrutareStudiu observațional
- Mayo Clinic in Rochester, Rochester
Family Study of Lymphoproliferative Disorders
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Mayo Clinic, Rochester
Q702 for the Treatment of Patients With Hematologic Malignancies
În curs de recrutareFaza 1
- Mayo Clinic in Rochester, Rochester
Studii pentru Leucemie limfatică cronică în alte orașe
- Boston, MA31 studii
- Columbus, OH28 studii
- Durham, NC27 studii
- Washington, DC22 studii
- Seattle, WA20 studii
- New York City, NY18 studii
- Houston, TX17 studii
- Baldwin Park, CA16 studii
- Milwaukee, WI15 studii
- Cincinnati, OH14 studii
- Chicago, IL14 studii
- Nashville, TN13 studii
Alte studii în Rochester
- Cancer de sân42 studii
- Cancer pulmonar cu celule non-pătrate37 studii
- Cancer metastatic31 studii
- Cancer (toate tipurile)30 studii
- Cancer colorectal29 studii
- Cancer ovarian29 studii
- Mielom multiplu24 studii
- Cancer de prostată22 studii
- Insuficiență cardiacă22 studii
- Cancer pancreatic22 studii
- Cancer pulmonar20 studii
- Cancer endometrial20 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.